Distal ischemic changes related to combination chemotherapy with cisplatin and gemcitabine: description of four cases.
نویسندگان
چکیده
Cancer chemotherapeutic agents have been related to three main forms of vascular toxicity: 1) Veno-occlusive disease of hepatic vessels or in rare instances, of pulmonary vessels [1]. 2) Venous or arterial thrombosis [2]. 3) Vascular ischemia involving cerebral, myocardial, or extremity arterial vessels [3]. The number of agents implicated in these toxicities is increasing (Table 1), although the precise pathogenesis of these toxic e¡ects has not been elucidated. Vascular changes may also be related to the underlying neoplasms or to unrecognized previous vascular disease, e.g., tobacco-related. Distal arterial ischemia is a rare complication induced by chemotherapy, and may be associated with preexistent organic changes. In the present article we report four cases of lung cancer and peripheral ischemia during chemotherapy with cisplatin and gemcitabine.
منابع مشابه
Digital ischemic events related to gemcitabine: Report of two cases and a systematic review
BACKGROUND Gemcitabine is a potent cytotoxic agent used in the treatment of many solid tumours, sarcomas and lymphomas. Vascular toxicity and thrombotic events related to gemcitabine seem to be underreported. CASE REPORT We report two cases of gemcitabine related digital ischemic events. Case 1. A 65-year-old man was given the first-line treatment with gemcitabine for the advanced adenocarcin...
متن کاملComparative study between two treatment regimens of Cisplatin-5-Fluorouracil and Gemcitabine-Cisplatin in gallbladder cancer patients
The research study was designed to compare the safety and efficacy of the regimen of 5-flurouracil with cisplatin of investigational arm with the reference regimen of gemcitabine with cisplatin for the treatment of gallbladder cancer. A total of 60 patients were enrolled in the study. Out of 30 patients enrolled in arm-A (Gemcitabine with Cisplatin) and 30 patients enrolled in arm-B (5-Fluroura...
متن کاملComparative study between two treatment regimens of Cisplatin-5-Fluorouracil and Gemcitabine-Cisplatin in gallbladder cancer patients
The research study was designed to compare the safety and efficacy of the regimen of 5-flurouracil with cisplatin of investigational arm with the reference regimen of gemcitabine with cisplatin for the treatment of gallbladder cancer. A total of 60 patients were enrolled in the study. Out of 30 patients enrolled in arm-A (Gemcitabine with Cisplatin) and 30 patients enrolled in arm-B (5-Fluroura...
متن کاملCan Thymidine Phosphorylase Be a Predictive Marker for Gemcitabine and Doxifluridine Combination Chemotherapy in Cholangiocarcinoma?
Unresectable cholangiocarcinoma is poorly responded to chemotherapy, especially for the case refractory to gemcitabine and cisplatin. Here, we tested whether high expression of thymidine phosphorylase (TP) can be a predictive biomarker for the indicator for gemcitabine and doxifluridine combination chemotherapy in the cholangiocarcinoma refractory to gemcitabine and cisplatin. Immunohistochemic...
متن کاملGemcitabine for the treatment of non-small-cell lung cancer.
Platinum-based chemotherapy regimens have been the mainstay of treatment for non-small-cell lung cancer because they improve survival. Although there is no standard platinum-based regimen, combination regimens with newer agents (e.g., gemcitabine [Gemzar], paclitaxel [Taxol], and vinorelbine [Navelbine]) are superior to platinum alone or in combination with older agents (e.g., etoposide). Four ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Annals of oncology : official journal of the European Society for Medical Oncology
دوره 11 9 شماره
صفحات -
تاریخ انتشار 2000